Article
Pharmacology & Pharmacy
Xu Jing, Dandan Ren, Fei Gao, Ye Chen, Xiao Wu, Yue Han, Qingsheng Han, Liang Li, Xiaojie Wang, Wei Tang, Yan Zhang
Summary: Recent studies have shown that PDCD4 plays a critical role in modulating signal transduction pathways in acute kidney injury (AKI). Inhibition of PDCD4 or tyrosine kinase Fgr, and targeting the NOTCH1 pathway may have therapeutic potential for mitigating AKI.
ACTA PHARMACEUTICA SINICA B
(2021)
Review
Pharmacology & Pharmacy
Tahib Habshi, Vishwadeep Shelke, Ajinath Kale, Maciej Lech, Anil Bhanudas Gaikwad
Summary: The transition from acute kidney injury (AKI) to chronic kidney disease (CKD) is a slow but continuous progression towards end-stage kidney disease. Previous research shows that Hippo components, such as YAP and TAZ, play a role in regulating inflammation and fibrogenesis during this transition. However, the roles and mechanisms of Hippo components differ during AKI, AKI-to-CKD transition, and CKD, highlighting the importance of understanding these roles in detail. This review explores the potential of Hippo regulators or components as future therapeutic targets for halting the AKI-to-CKD transition.
DRUG DISCOVERY TODAY
(2023)
Article
Urology & Nephrology
Simon Sawhney, Samira Bell, Corri Black, Christian Fynbo Christiansen, Uffe Heide-Jorgensen, Simon Kok Jensen, Paul E. Ronksley, Zhi Tan, Marcello Tonelli, Heather Walker, Matthew T. James
Summary: Using a consistent analytical approach and KDIGO criteria, the study found that the incidence and prognosis of AKI and AKD are consistent in three high-income countries. The age-standardized incidence rates were similar across regions and years, and the standardized 1-year mortality varied among patients meeting different creatinine criteria.
KIDNEY INTERNATIONAL
(2022)
Article
Cardiac & Cardiovascular Systems
Nans Florens, Rajesh K. Kasam, Valeria Rudman-Melnick, Suh-Chin Lin, Vikram Prasad, Jeffery D. Molkentin
Summary: This study investigated the mechanism of cardiac remodeling induced by acute kidney injury (AKI) using mouse models. The results showed that IL-33 released from the kidney during AKI directly affected cardiac myocytes, leading to cardiac hypertrophy and cardiomyopathy. These findings suggest that antagonizing the IL-33/ST2 axis may have cardioprotective effects in patients with kidney disease.
Article
Medicine, General & Internal
Filipe Marques, Joana Gameiro, Joao Oliveira, Jose Agapito Fonseca, Ines Duarte, Joao Bernardo, Carolina Branco, Claudia Costa, Carolina Carreiro, Sandra Braz, Jose Antonio Lopes
Summary: The study retrospectively analyzed COVID-19 patients with AKI admitted at Centro Hospitalar Universitario Lisboa Norte between March and August 2020. It found that factors such as hypertension, CKD, lower hemoglobin and CRP levels, as well as nephrotoxin exposure were independent risk factors for the development of AKD. Older age, higher serum ferritin levels at admission, and development of AKD were independent predictors of in-hospital mortality in COVID-19-AKI patients.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Medicine, Research & Experimental
Dennis G. Moledina, Wassim Obeid, Rex N. Smith, Ivy Rosales, Meghan E. Sise, Gilbert Moeckel, Michael Kashgarian, Michael Kuperman, Kirk N. Campbell, Sean Lefferts, Kristin Meliambro, Markus Bitzer, Mark A. Perazella, Randy L. Luciano, Jordan S. Pober, Lloyd G. Cantley, Robert B. Colvin, F. Perry Wilson, Chirag R. Parikh
Summary: In this study, urinary CXCL9 was identified as a diagnostic biomarker for acute tubulointerstitial nephritis (AIN) using urine proteomics. This finding was confirmed in multiple validation cohorts and higher expression of CXCL9 was observed in kidney biopsies from AIN patients. This discovery has important implications for the early diagnosis and treatment of AIN.
JOURNAL OF CLINICAL INVESTIGATION
(2023)
Article
Medicine, Research & Experimental
Yi Chen, Liyu Lin, Siyi Rao, Xuan Tao, Jiong Cui, Jianxin Wan
Summary: This study aimed to investigate the mechanism of how complement C3a mediates podocyte injury during ischemia-reperfusion acute kidney injury (IR-AKI) and post-injury fibrosis. An IR-AKI and post-injury fibrosis model was established using renal artery clamping. The results showed that C3(-/-) led to improvement in renal dysfunction by reducing podocyte damage and renal fibrosis. Immunoblot analysis indicated that C3(-/-) decreased TLR4/NF?B-P65 in renal tissue homogenates from IR-AKI mice.
EUROPEAN JOURNAL OF MEDICAL RESEARCH
(2023)
Article
Urology & Nephrology
Lingyu Xu, Chenyu Li, Na Li, Long Zhao, Zhihui Zhu, Xiaosu Zhang, Jing Wang, Jun Zhao, Junyan Huang, Zhihua Zheng, Hans-Joachim Anders, Yan Xu
Summary: This study investigates the risk factors and prognosis of acute/subacute renal impairment among Chinese inpatients. It finds that AKI followed by AKD is associated with a higher risk of long-term mortality compared to AKD without AKI and recovery from AKI. The study also suggests that AKD criteria are strongly associated with overall survival and de novo CKD, while AKI criteria have a relatively lower ability to predict the risk of overall survival and CKD.
CLINICAL KIDNEY JOURNAL
(2023)
Article
Multidisciplinary Sciences
Ping Yan, Xiang-Jie Duan, Yu Liu, Xi Wu, Ning-Ya Zhang, Fang Yuan, Hao Tang, Qian Liu, Ying-Hao Deng, Hong-Shen Wang, Mei Wang, Shao-bin Duan
Summary: A study on 2,556 hospitalized AKI patients in three tertiary hospitals in China in 2015 found that AKD is common among these patients. AKD stage 2-3 provides additional predictive value for adverse outcomes at 30 days and one year compared to AKD stage 0.
Article
Physiology
Fan Yang, Elyce Ozols, Frank Y. Ma, Khai Gene Leong, Greg H. Tesch, Xiaoyun Jiang, David J. Nikolic-Paterson
Summary: The JNK signaling pathway plays a role in acute high dose AA-induced kidney injury, but is not essential in promoting chronic kidney disease caused by ongoing DNA damage from chronic low dose AA exposure.
FRONTIERS IN PHYSIOLOGY
(2021)
Article
Immunology
Jiefu Zhu, Yafei Zhang, Lang Shi, Yao Xia, Hongchu Zha, Huimin Li, Zhixia Song
Summary: This study reveals the protective role of RP105 in ischemic and septic acute kidney injury (AKI). Overexpression of RP105 alleviated renal structural injuries and dysfunction caused by ischemic and septic AKI. RP105 suppressed inflammatory responses mediated by the TLR4 signaling pathway. These findings suggest that RP105 could be a potential target for preventing and treating ischemic and septic AKI.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Review
Immunology
Jiaye Liu, Zhanjun Jia, Wei Gong
Summary: Mitochondrial dysfunction plays a critical role in the occurrence and progression of acute kidney injury (AKI). Damaged mitochondria release mtDNA which can activate the innate immune system, leading to renal inflammation and apoptosis. Regulating proteins involved in these pathways may be an effective strategy to reduce renal tubular injury and alleviate AKI.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Pharmacology & Pharmacy
Huapan Shu, Yumei Wang, Hui Zhang, Qingqing Dong, Lulu Sun, Yuchi Tu, Qianqian Liao, Li Feng, Lijun Yao
Summary: The profibrotic phenotype of renal tubular epithelial cells (TECs) and the accumulation of CD206(+) M2 macrophages play important roles in the transition from acute kidney injury (AKI) to chronic kidney disease (CKD). However, the mechanisms underlying this transition are not well understood. In this study, the researchers investigated the role of serum and glucocorticoid-inducible kinase (SGK) and T-LAK-cell-originated protein kinase (TOPK) in the AKI-CKD transition. They found that SGK3 inhibited epithelial to mesenchymal transition (EMT) in TECs while promoting M2 macrophage polarization, and TOPK phosphorylation mediated the crosstalk between TECs and macrophages during the transition.
FRONTIERS IN PHARMACOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Saiqi Qi, Jie Song, Linjun Chen, Huachun Weng
Summary: This article addresses the important roles of m6A modification in kidney diseases and its molecular mechanisms. The m6A modification has been shown to regulate RNA expression through splicing, export, attenuation, and translation initiation efficiency. Understanding the impact of m6A modification in kidney diseases can provide valuable insights for diagnosis and clinical management.
MOLECULAR MEDICINE
(2023)
Review
Medical Laboratory Technology
Adam Rossiter, Ashley La, Jay L. Koyner, Lui G. Forni
Summary: Acute kidney injury (AKI) is a commonly encountered clinical syndrome, especially in hospitalized patients, particularly those who are critically ill or who have undergone major surgery. AKI is associated with an increase in both mortality and morbidity, and efforts have focused on new biomarkers associated with AKI that may allow early recognition of this syndrome with improved patient outcomes.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
(2023)